Table 2.
Total (n) | 33 |
Male n (%) | 20 (60%) |
Age (Median, IQR) | 5 (1 – 17 yr) |
COVID-19 Clinical syndrome | n (%) |
Mild | 22 (67%) |
Moderate | 3 (9%) |
Severe | 2 (6%) |
Asymptomatic | 6 (18%) |
Clinical Symptoms | |
Fever | 28 (86%) |
Respiratory | 10 (31%) |
Gastrointestinal | 8 (23%) |
Underlying conditions (n = 6) | |
Acute lymphoblastic leukaemia | 2 |
Neurodevelopmental delay | 1 |
Nephrotic syndrome | 1 |
Inborn error of metabolism | 1 |
Iron deficiency Anaemia | 1 |
Co-existing infection/condition (n = 4) | |
Urinary tract infection | 2 |
Brucellosis | 1 |
Tuberculosis | 1 |